system makes this valuable, reproducible, and ethically approved platform for testing nephrotoxicity and hepatotoxicity accessible to more laboratories, for example for dose finding or compound prioritisation, thereby supporting 3R-conform preclinical drug screening as well as hazard identification and potentially reducing reliance on animal experiments.
Spruck et al. (Tue,) studied this question.